Avanos Medical AVNS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Avanos Medical (AVNS) Business Model and Operations Summary
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Key Insights
Avanos Medical (AVNS) Core Market Data and Business Metrics
Latest Closing Price
$14.52Market Cap
$667.97 MillionPrice-Earnings Ratio
-1.70Total Outstanding Shares
46 Million SharesTotal Employees
2,227Dividend
No dividendIPO Date
October 21, 2014SIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
New York Stock ExchangeHeadquarters
5405 Windward Parkway, Alpharetta, GA, 30004
Historical Stock Splits
If you bought 100 shares of AVNS before May 15, 2006, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| May 15, 2006 | 1-for-100 (Reverse Split) |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 454,697 Shares | 1.75 | 3/14/2025 | 796,523 Shares |
| 558,378 Shares | 1.59 | 2/28/2025 | 888,743 Shares |
| 303,243 Shares | 2.33 | 2/14/2025 | 706,950 Shares |
| 628,351 Shares | 1.01 | 1/31/2025 | 631,975 Shares |
| 756,197 Shares | 1 | 1/15/2025 | 666,867 Shares |
| 444,488 Shares | 1.53 | 12/31/2024 | 681,404 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $-4.10 Million |
| Net Cash Flow From Investing Activities, Continuing | $-27.50 Million |
| Net Cash Flow From Operating Activities, Continuing | $100.70 Million |
| Net Cash Flow From Financing Activities, Continuing | $-49.10 Million |
| Net Cash Flow From Financing Activities | $-49.10 Million |
| Net Cash Flow, Continuing | $24.10 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Selling, General, and Administrative Expenses | $318.50 Million |
| Income Tax Expense/Benefit, Current | $18.90 Million |
| Income/Loss From Discontinued Operations Net Of Tax | $-5.80 Million |
| Income/Loss From Continuing Operations Before Tax | $-403.30 Million |
| Research and Development | $26.20 Million |
| Cost Of Revenue | $306.50 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $-409.70 Million |
| Other Comprehensive Income/Loss | $-409.70 Million |
| Comprehensive Income/Loss Attributable To Parent | $-409.70 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-17.60 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Parent | $828.50 Million |
| Other Current Assets | $121.80 Million |
| Current Liabilities | $165.90 Million |
| Other Current Liabilities | $111.60 Million |
| Liabilities | $325.70 Million |
| Noncurrent Liabilities | $159.80 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||